AZN beats third-quarter estimates for earnings and sales. It raises its sales and profit outlook for 2024 for the second time ...

Johnson East took Bear in for his shot during his first pediatrician appointment. “He handled it very well,” she remembers. “We didn’t see any side effects with him. We were walked through the side ...

In the prior year period, Core EPS included gains totalling $953m from the disposal of Pulmicort Flexhaler US rights and updated contractual arrangements for Beyfortus Guidance for FY 2024 Total ...

A new government program will give pregnant mothers and newborns free access to RSV vaccines, a move that is expected to ...

Pregnant mums and newborns will receive free vaccinations against respiratory syncytial virus (RSV) under the federal ...

Nationwide RSV immunisation program to keep 10,000 babies out of hospitalImmunisation advocates are heralding the Albanese Government's commitment to ...

The respiratory virus is the leading cause of hospitalisation for infants, with 12,000 babies admitted each year. Before next ...

RSV vaccination for infants and mothers should be administered either in the hospital or directly from a primary health-care ...

Key Takeaways Zacks earnings estimates for AstraZeneca are currently at $4.06 per share. However, the earnings picture ...